UBS AM Portfolio holdings
UBS AM is the US asset manager of UBS and grew out of Brinson Partners, an investment firm founded by Gary Brinson and made independent in 1989. Swiss Bank Corporation bought Brinson Partners in 1994, and once the bank merged with UBS, its founder Gary Brinson, who had run Swiss Bank's asset management business, became chief investment officer of UBS Asset Management. In 2024 the business took in Credit Suisse Asset Management and two of its own units, UBS Hedge Fund Solutions and UBS O’Connor, though the O’Connor business was later sold. Its clients are mainly institutions such as retirement plans, government bodies, endowments and foundations.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$1.32B |
| 2 |
Digital Realty Trust
DLR
|
+$931M |
| 3 |
Western Digital
WDC
|
+$895M |
| 4 |
Simon Property Group
SPG
|
+$736M |
| 5 |
Realty Income
O
|
+$643M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.73B |
| 2 |
Eaton
ETN
|
+$1.21B |
| 3 |
Seagate
STX
|
+$1.1B |
| 4 |
Trane Technologies
TT
|
+$1.02B |
| 5 |
Accenture
ACN
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.05% |
| 2 | Financials | 11.12% |
| 3 | Healthcare | 9.54% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2326
Pony AI Inc
PONY
$2.02B
| $950K | ﹤0.01% |
136,756
-25,800
| -16% | -$239K |
2025 Q4
2 quarters
|
|
2327
Bristow Group
VTOL
$1.24B
| $946K | ﹤0.01% |
22,905
| – | – |
2023 Q4
10 quarters
|
|
2328
Nokia
NOK
$47.9B
| $943K | ﹤0.01% |
70,985
| – | – |
2025 Q4
2 quarters
|
|
2329
Sinclair Inc
SBGI
$926M
| $939K | ﹤0.01% |
65,875
-875
| -1% | -$12.6K |
2013 Q2
52 quarters
|
|
2330
Aeva Technologies
AEVA
$646M
| $936K | ﹤0.01% |
32,605
+13,746
| +73% | +$271K |
2025 Q3
3 quarters
|
|
2331
Tilray
TLRY
$374M
| $935K | ﹤0.01% |
208,229
+11,894
| +6% | +$68.1K |
2020 Q1
25 quarters
|
|
2332
NovaGold Resources
NG
$2.55B
| $933K | ﹤0.01% |
156,209
+150,989
| +2,893% | +$1.26M |
2025 Q4
2 quarters
|
|
2333
iShares Euro High Yield Corporate Bond USD Hedged ETF
EUHY
$248M
| $926K | ﹤0.01% |
17,199
| – | – |
2026 Q1
1 quarter
|
|
2334
iShares Expanded Tech-Software Sector ETF
IGV
$13.8B
| $925K | ﹤0.01% |
10,205
-814
| -7% | -$72.4K |
2025 Q4
2 quarters
|
|
2335
Fulgent Genetics
FLGT
$567M
| $924K | ﹤0.01% |
45,020
-56,283
| -56% | -$954K |
2020 Q4
22 quarters
|
|
2336
NIO
NIO
$8.04B
| $918K | ﹤0.01% |
181,351
| – | – |
2019 Q1
29 quarters
|
|
2337
Vanguard FTSE Pacific ETF
VPL
$8.43B
| $915K | ﹤0.01% |
7,906
-12,054
| -60% | -$1.33M |
2025 Q4
2 quarters
|
|
2338
Arvinas
ARVN
$514M
| $914K | ﹤0.01% |
109,966
-1,008
| -0.9% | -$9.4K |
2019 Q4
26 quarters
|
|
2339
Janux Therapeutics
JANX
$1.07B
| $907K | ﹤0.01% |
59,019
-28,738
| -33% | -$416K |
2024 Q1
9 quarters
|
|
2340
Ibotta
IBTA
$980M
| $902K | ﹤0.01% |
26,419
| – | – |
2024 Q3
7 quarters
|
|
2341
Takeda Pharmaceutical
TAK
$66.8B
| $899K | ﹤0.01% |
56,108
| – | – |
2025 Q4
2 quarters
|
|
2342
MetroCity Bankshares
MCBS
$1.03B
| $899K | ﹤0.01% |
25,046
-724
| -3% | -$23.6K |
2022 Q4
14 quarters
|
|
2343
Orrstown Financial Services
ORRF
$864M
| $897K | ﹤0.01% |
21,980
| – | – |
2024 Q4
6 quarters
|
|
2344
Genmab
GMAB
$35.1B
| $896K | ﹤0.01% |
32,612
-32
| -0.1% | -$850 |
2025 Q4
2 quarters
|
|
2345
CorMedix
CRMD
$444M
| $893K | ﹤0.01% |
113,740
-58,142
| -34% | -$459K |
2025 Q1
5 quarters
|
|
2346
Atlanticus Holdings
ATLC
$1.42B
| $892K | ﹤0.01% |
8,726
| – | – |
2025 Q1
5 quarters
|
|
2347
Amphastar Pharmaceuticals
AMPH
$1.18B
| $889K | ﹤0.01% |
44,062
-11,313
| -20% | -$228K |
2015 Q1
45 quarters
|
|
2348
WisdomTree Trust WisdomTree US SmallCap Quality Dividend Growth Fund
DGRS
$391M
| $885K | ﹤0.01% |
14,907
| – | – |
2026 Q1
1 quarter
|
|
2349
Oil-Dri
ODC
$1.03B
| $882K | ﹤0.01% |
8,629
-300
| -3% | -$24K |
2025 Q3
3 quarters
|
|
2350
Elbit Systems
ESLT
$36.5B
| $881K | ﹤0.01% |
1,161
| – | – |
2025 Q4
2 quarters
|
|
Similar funds
UBS AM's Q2 2026 Portfolio in Review
As of Q2 2026, UBS AM held 3,886 positions worth $550B, up 14% from $481B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
UBS AM's Q2 2026 filing shows 45 new, 996 increased, 1,636 reduced and 163 closed positions. Its largest new stake was Honeywell Aerospace: 1,676,062 shares worth $371M. The largest sale was Linde, an estimated $1.73B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q2 2026 buy was Honeywell Aerospace: 1,676,062 shares worth $371M.
- UBS AM added most to Equinix in Q2 2026, an estimated $1.32B increase.
- UBS AM's biggest Q2 2026 reduction was Linde, cutting an estimated $1.73B.
- UBS AM fully exited Hologic in Q2 2026, selling an estimated $174M.
- UBS AM's ten largest holdings make up 33% of its $550B portfolio in Q2 2026.
- UBS AM opened 45 new positions and closed 163 in Q2 2026.
- UBS AM's portfolio value rose 14% quarter-over-quarter to $550B.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.